SynthesisFrontiers in immunology2026

Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies.

Jiahao Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.